PACIFIC HEALTH CARE ORGANIZATION INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that PACIFIC HEALTH CARE ORGANIZATION INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.72M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $6.07M | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | $5.63M | Mar 19, 2025 |
| FY2023 | Dec 31, 2022 | $5.74M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $5.40M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $6.04M | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | $7.33M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $6.80M | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $6.51M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $5.69M | Apr 2, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.39M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $883.6K | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | $767.9K | Mar 19, 2025 |
| FY2023 | Dec 31, 2022 | $492.9K | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $995.0K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $549.6K | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | $1.20M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $1.36M | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $964.4K | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $566.7K | Apr 2, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.00M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $852.6K | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | $678.5K | Mar 19, 2025 |
| FY2023 | Dec 31, 2022 | $666.1K | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $516.5K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $820.3K | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | $1.68M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $1.89M | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $1.69M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $969.3K | Apr 2, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.16M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $675.1K | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | $932.4K | Mar 19, 2025 |
| FY2023 | Dec 31, 2022 | $711.2K | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $386.4K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $987.4K | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | $1.09M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $1.32M | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $826.1K | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $1.21M | Apr 2, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $23.3K | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $9.1K | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | $17.5K | Mar 19, 2025 |
| FY2023 | Dec 31, 2022 | $38.9K | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $18.4K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $53.8K | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | $59.2K | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $41.7K | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $16.7K | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $42.5K | Apr 2, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.46M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $12.43M | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | $11.75M | Mar 19, 2025 |
| FY2023 | Dec 31, 2022 | $12.05M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $11.33M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $11.11M | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | $10.25M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $8.51M | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $7.26M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $6.26M | Apr 2, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $745.6K | Mar 19, 2025 |
| FY2024 | Dec 31, 2023 | $948.3K | Mar 19, 2025 |
| FY2023 | Dec 31, 2022 | $735.1K | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $508.5K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $1.28M | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | $974.1K | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $424.0K | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $538.6K | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $499.0K | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $384.9K | Mar 31, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.07M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $11.69M | Mar 18, 2026 |
| FY2025 | Dec 31, 2023 | $10.80M | Mar 18, 2026 |
| FY2024 | Dec 31, 2022 | $11.32M | Mar 19, 2025 |
| FY2023 | Dec 31, 2021 | $10.82M | Apr 16, 2024 |
| FY2022 | Dec 31, 2020 | $9.83M | Mar 31, 2023 |
| FY2021 | Dec 31, 2019 | $9.28M | Apr 14, 2022 |
| FY2020 | Dec 31, 2018 | $8.08M | Mar 31, 2021 |
| FY2019 | Dec 31, 2017 | $6.72M | Mar 26, 2020 |
| FY2018 | Dec 31, 2016 | $5.76M | Mar 29, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.65M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $11.26M | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | $10.37M | Mar 19, 2025 |
| FY2023 | Dec 31, 2022 | $10.89M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $10.40M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $9.40M | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | $8.85M | Mar 31, 2021 |
| FY2022 | Jan 1, 2019 | $0 | Mar 31, 2023 |
| FY2019 | Dec 31, 2018 | $7.65M | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $6.29M | Mar 29, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.17M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $2.07M | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | $2.49M | Mar 19, 2025 |
| FY2023 | Dec 31, 2022 | $2.04M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $10.09M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $9.50M | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | $8.10M | Mar 31, 2021 |
| FY2020 | Dec 31, 2018 | $7.07M | Mar 31, 2021 |
| FY2019 | Dec 31, 2017 | $5.82M | Mar 26, 2020 |
| FY2018 | Dec 31, 2016 | $5.01M | Mar 29, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 19, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Apr 2, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 19, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Apr 2, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 12.80M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | 12.80M | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | 12.80M | Mar 19, 2025 |
| FY2023 | Dec 31, 2022 | 12.80M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | 12.80M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 12.80M | Apr 14, 2022 |
| FY2020 | Dec 31, 2019 | 12.80M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 12.80M | Mar 26, 2020 |
| FY2020 | Apr 5, 2018 | 12.80M | Mar 31, 2021 |
| FY2018 | Dec 31, 2017 | 3.20M | Mar 29, 2019 |